dr. philip on the impact of the prodige 24/cctg pa.6 study in pancreatic cancer
Published 5 years ago • 91 plays • Length 1:30
Download video MP4
Download video MP3
Similar videos
-
1:26
dr. philip on folfirinox in locally advanced pancreatic cancer
-
1:31
dr. philip on the importance of developing new drugs for pancreatic cancer
-
1:17
dr. philip philip on choosing the right treatment for advanced pancreatic cancer patients
-
2:29
dr. philip on drug developments for pancreatic cancer
-
2:43
philip philip, md, phd, frcp, considers the impact of immunotherapy agents in pancreatic cancer
-
1:45
dr. philip on evofosfamide for pancreatic cancer
-
2:30
#esmo21 highlights on gemcitabine vs mfolfirinox in resected pancreatic cancer: prodige 24/cctg pa6
-
2:17
philip philip, md, reflects on the impact of pegph20 in met pancreatic cancer
-
2:04
philip philip, md, shares opinion on treatment of a brca pancreatic cancer patient
-
2:51
philip philip, md, phd, frcp, on the implications of the lapact study presented at asco 2018
-
38:24
current and future directions in metastatic pancreatic cancer
-
4:45
philip philip, md, on whether resected pancreatic cancer patients should be offered adjuvant therapy
-
1:52
dr. laber on the prodige 35-panoptimox trial in metastatic pancreatic cancer
-
7:59
advanced pancreatic cancer: options in the adjuvant setting
-
3:00
philip philip, md, on the phase 2 study comparing chemo with or without veliparib in pancreas
-
1:00
dr. simeone on benefit of neoadjuvant gemcitabine in pancreatic cancer
-
4:42
philip philip md, phd, frcp, on the apact trial in surgically resected pancreatic adenocarcinoma
-
2:03
philip philip md, phd, frcp, on neoadjuvant chemotherapy & upfront surgery in pancreatic cancer
-
1:29
dr. ocean on the development of nanoliposomal irinotecan in metastatic pancreatic cancer
Clip.africa.com - Privacy-policy